Using Tractography to Distinguish SWEDD from Parkinson's Disease Patients Based on Connectivity by Kim, M & Hyunjin Park
Research Article
Using Tractography to Distinguish SWEDD from
Parkinson’s Disease Patients Based on Connectivity
Mansu Kim1 and Hyunjin Park2,3
1Department of Electronic, Electrical and Computer Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea
2School of Electronic and Electrical Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea
3Center for Neuroscience Imaging Research (CNIR), Institute for Basic Science, Suwon 16419, Republic of Korea
Correspondence should be addressed to Hyunjin Park; hyunjinp@skku.edu
Received 28 October 2015; Revised 3 February 2016; Accepted 10 February 2016
Academic Editor: Carlo Colosimo
Copyright © 2016 M. Kim and H. Park.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. It is critical to distinguish between Parkinson’s disease (PD) and scans without evidence of dopaminergic deficit
(SWEDD), because the two groups are different and require different therapeutic approaches.Objective.The aim of this study was to
distinguish SWEDDpatients from PD patients using connectivity information derived from diffusion tensor imaging tractography.
Methods. Diffusion magnetic resonance images of SWEDD (𝑛 = 37) and PD (𝑛 = 40) were obtained from a research database.
Tractography, the process of obtaining neural fiber information, was performed using custom software. Group-wise differences
between PD and SWEDD patients were quantified using the number of connected fibers between two regions, and correlation
analyses were performed based on clinical scores. A support vector machine classifier (SVM) was applied to distinguish PD and
SWEDD based on group-wise differences. Results. Four connections showed significant group-wise differences and correlated with
the Unified Parkinson’s Disease Rating Scale sponsored by the Movement Disorder Society. The SVM classifier attained 77.92%
accuracy in distinguishing between SWEDD and PD using these identified connections. Conclusions. The connections and regions
identified represent candidates for future research investigations.
1. Introduction
Parkinson’s disease (PD), the second most common neu-
rodegenerative disease in the elderly, causes the loss of
dopaminergic neurons in the brainstem, especially those in
the substantia nigra [1]. Characteristic PD symptoms include
resting tremor, rigidity, impaired voluntary movement, and
cognitive impairment [2]. PD is typically diagnosed by crite-
ria such as those of the United Kingdom’s Parkinson’s Disease
Society Brain Bank [3]. However, about 10% of clinically
diagnosed PD patients do not lose dopaminergic neurons in
the brainstem and are classified as scans without evidence
of dopaminergic deficit (SWEDD) [4]. SWEDD is a nuclear
medicine term referring to patients with PD that show no
evidence of dopamine transporter deficit. The etiology of
SWEDD has been under debate; some consider it an early
phase of PD, while others consider it a different disease [5].
Distinguishing between PD and SWEDD is important, as the
two groups are potentially different and thus may require
different therapeutic strategies.
Diffusion tensor imaging (DTI), an MRI imaging tech-
nique, quantifies in vivo neuronal fiber information using
anisotropic water diffusion in thewhitematter.This approach
has been used to differentiate between normal controls
(NCs) and PD patients [6–8]. DTI has a few limitations
and is unable to distinguish between efferent and afferent
connections; however, it is the only practical option for
assessing in vivo fiber information [9]. Raw data from DTI
need to be processed with an algorithm in a process known
as tractography so that relevant fiber information can be
extracted [10]. Extracted fiber information is further analyzed
with connectivity analysis, which is suitable for analyzing
complex objects such as the brain. Connectivity derived
from DTI is known as structural connectivity, because DTI
is related to actual neuronal fiber connections between
regions. Many studies have also derived brain connectivity
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information from resting state functionalMRI (fMRI), which
measures local brain activity based on the blood oxygen level-
dependent (BOLD) effect [11].
Connectivity analysis requires that regions of interest
(ROIs) are specified in order to explore correlations or
connections among the regions. These ROIs can be specified
by coregistering information from a predefined parcellation
of the brain, which can be derived from structural or func-
tional information [12]. Brain connectivity has been explored
for analysis of motor-related regions previously known to
be affected by PD [13]. Structural connectivity of cortico-
cortical, cortical-subcortical, and subcortical connections in
cortico-basal ganglia-thalamocortical (CBTC) connections
was investigated in this study. Connectivity measures can be
used to quantify group-wise differences and as biomarkers
of important clinical variables in PD research. Many studies
have successfully established group-wise differences between
PD patients and NCs based on neuroimaging [2, 6–8, 13–15].
However, less attention has been paid to differences between
PD and SWEDD patients.Thus, the focus of this study was to
quantify differences between PD and SWEDD patients based
on connectivity information from DTI tractography.
We obtained diffusionMRI data from the Parkinson’s dis-
ease Progressive Marker Institute (PPMI) research database
[16]. Connectivity analysis was applied to PD and SWEDD
patients. Group-wise differences between PD and SWEDD
patients were quantified using the number of neuronal
fibers connecting regions as features. We tried to identify
connections between regions with significant group-wise
differences in terms of the number of neuronal fibers and then
find significant correlations between the number of fibers
that connected specific regions and the Movement Disorder
Society-sponsored Unified Parkinson’s Disease Rating Scale
(MDS-UPDRS).
2. Material and Methods
2.1. Subjects. Our study was a retrospective analysis of anon-
ymized imaging data, and local IRB approval was obtained.
The PPMI is an observational clinical study to evaluate PD
and other closely related cohorts using advanced imaging,
biological sampling, and clinical and behavioral assessments
to identify potential biomarkers of progression of PD [16].
The PPMI includes a database where imaging and clini-
cal/behavioral assessments data are shared with the scientific
community.The study included 423 de novo PD, 64 SWEDD,
and 196 normal control cases as of July 2015. Our study
explored subjects with MRI imaging data aside from the
usual SPECT. Our SWEDD group was limited to 37 SWEDD
patients who underwent DTI and structural MRI imaging.
We included a total of 77 participants and classified them
into SWEDD (𝑛 = 37) and PD (𝑛 = 40) groups that
were matched according to age and sex ratio. Subgroups
were classified based on PPMI consortium guidelines [16].
Detailed criteria for the SWEDD group are as follows. First,
patients had to demonstrate at least two of the following
symptoms: resting tremor, bradykinesia, rigidity, or either
asymmetric resting tremor or bradykinesia. Second, patients
had to have been diagnosed with PD for 2 years or less at the
Table 1: Participant information: values are reported as mean ±
standard deviation (SD).
SWEDD PD 𝑃 value
Number of subjects 𝑛 = 37 𝑛 = 40 —
Age (years) 61.3 ± 10.9 59.5 ± 11.0 0.403
Sex (male/female) 24/13 21/19 0.264
Disease duration (months) 6.4 ± 7.9 5.58 ± 4.7 0.587
Hoehn & Yahr score 1.6 ± 0.5 1.5 ± 0.5 0.921
MDS-UPDRS-III score 14.0 ± 9.1 18.6 ± 8.1 0.752
GDS score 3.3 ± 3.7 2.6 ± 3.1 0.392
MoCA score 27.4 ± 1.8 28.1 ± 2.1 0.103
time of screening, with no evidence of dopamine transporter
deficit on dopamine transporter SPECT imaging. Third,
patients had to have been free of PD medication for at least
6 months. Fourth, patients were 30 years or older at the time
of PD diagnosis. Participant information, including scores of
MDS-UPDRS,Montreal Cognitive Assessment (MoCA), and
Geriatric Depression Scale (GDS), is given in Table 1. The
disease duration of all (𝑛 = 422) available PD patients in the
PPMI database was 6.57 ± 6.51 months (mean ± SD), which
was not significantly different from the PD group used in our
study (𝑃 = 0.343). The imaging data of PD and SWEDD
were from baseline scans of patients not using any PD-related
medication.
2.2. Imaging Data. We obtained diffusion and T1- and
T2-weighted MRI data from the PPMI database [16]. We
obtained T1- and T2-weighted MR imaging in addition to
the DTI data because the image preprocessing steps were
required in T1- and T2-weighted MR imaging. T1- and
T2-weighted MRI data were obtained using the following
parameters: TR = 2300ms, TE = 2.98ms, TI = 900ms, image
matrix = 240 × 256 × 176, and voxel resolution = 1 × 1
× 1mm3. Parameters for the T2-weighted images were as
follows: TR = 3000ms, TE = 101ms, image matrix = 228 ×
256 × 48, and voxel resolution = 0.9375 × 0.9375 × 3mm3.
Diffusion images were obtained with a Siemens 3T scanner
using the following parameters: 3T scanner, 𝑏 = 1000 s/mm2,
64 diffusion gradient directions with one 𝑏0 image, image
matrix = 116 × 116 × 72, and voxel resolution = 1.98 × 1.98
× 2mm3.
2.3. Image Preprocessing. Preprocessing steps were per-
formed to extract fiber information from DTI data. Readers
interested in details of the preprocessing steps are referred
to a review article [17]. Briefly, image preprocessing was per-
formed using the Connectome Mapping Toolkit (CMTK), a
Python-based open-source software (http://www.cmtk.org/).
T1- and T2-weighted images were aligned to the non-
diffusion-weighted image (𝑏0) by a nonlinear registration
using FSL for each subject [18]. The registered T1-weighted
image was segmented into white matter, grey matter, and
cerebrospinal fluid using FreeSurfer [19]. The segmented
white matter was then used to guide the tractography algo-
rithm. An overview of image preprocessing procedures is
provided in Figure 1.
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Table 2: Motor-related regions that were explored for connectivity.
Cortical cluster ROIs Cortical cluster ROIs
Motor, premotor cortex Caudal middle frontal Postcentral
Precentral Parietal lobe Supramarginal
Dorsal lateral prefrontal cortex (DLPFC)
Frontal pole Superior parietal
Rostral middle frontal Inferior parietal
Pars triangularis Thalamus proper
Pars orbitalis Caudate
Cingulate motor area (CMA) Rostral anterior cingulate Subcortical Putamen
Posterior cingulate Pallidum
Supplementary motor area (SMA) Paracentral Accumbens area
Superior frontal Brainstem Brainstem
Registration ParcellationSegmentation
Tractography
Construction matrix
Diffusion weighted image
T2
T1
White matter
Gray matter Connectivity matrix
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Figure 1: Overall image preprocessing procedures.
2.4. ROI Specifications. Exploring connectivity requires that
the ROIs are specified so that correlations among them
can be investigated. We coregistered and transferred infor-
mation from a predefined atlas onto the individual sub-
ject image spaces to specify the ROIs using the Desikan-
Killiany anatomical atlas [12]. Our analysis focused on the
39 motor-related regions known to be affected by PD. A
full list of explored regions is provided in Table 2 [13].
The regions include the motor cortex, premotor cortex,
dorsal lateral prefrontal cortex (DLPFC), cingulate motor
area, supplementary motor area (SMA), and a few regions
in the parietal lobe, subcortex, and brainstem. The cortico-
cortical connections mediate hand, face, foot, and trunk
motor activity [20]. The CBTC connection has been shown
to be important in PD patients [21]. Fiber connections from
the brainstem were included to explore the initiation and
control of movement [22]. Connections from the brainstem
were considered because this structure is densely connected
with the pallidum and substantia nigra, which are important
regions affected by PD. Connections among these regions
were explored to quantify structural connectivity of cortico-
cortical, cortical-subcortical, and subcortical connections.
2.5. Tractography and Network Construction. Eddy current-
induced distortions and head motion were corrected with
FSL [18]. Fiber information was computed using the FACT
algorithm implemented within the Diffusion Toolkit and
CMTK software [17]. The FACT algorithm propagated a
line from the center of a seed voxel along the direction of
the dominant vector, which was determined by the largest
eigenvector of the tensor. The starting point of the next voxel
was the intercept of the previous voxel. Tracking terminated
when the algorithm reached a region with an abrupt change
in fiber direction (i.e., angle threshold greater than 60∘).
Tracking was limited to white matter and its neighbors, as
neuronal fibers mainly exist in the white matter. Every voxel
was considered a seed voxel, and we retained only fibers
whose end points were within the predefined ROIs.
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Figure 2: Connections and group-wise differences. Significantly different connections were rendered (a), and corrected𝑃 values were plotted
(b).
Connectivity was assessed using nodes and edges of a
graph. Nodes were assigned ROIs that were transferred from
the predefined parcellation. Each edge value was assumed
to be the number of fibers whose end points resided within
two ROIs, which was entered into the matrix as an element.
Elements with less than 5 fibers were excluded, as identi-
fication of a very small number of fibers was considered
to be an unstable result of the tractography algorithm [23].
The matrix was referred to as the connectivity matrix. We
adopted a simple network model that considered undirected
and weighted edges.
2.6. Statistical Tests. Group-wise differences between SWEDD
and PD groups were explored in 39 regions. For each group,
the connectivity matrices of the two groups (i.e., PD and
SWEDD) were stacked into two three-dimensional matrices.
Each element in the stacked connectivity matrix contained
many observations (i.e., 37 or 40 observations), which were
tested using nonparametric permutation tests to distinguish
between PD and SWEDD. Permutation tests were performed
by randomly assigning PD and SWEDD subjects 10,000
times. One permutation involved randomly assigning the
first 37 cases to the SWEDD group and the remaining
40 cases to the PD group. Differences in the number of
fibers were deemed significant if they did not belong to the
95th percentile of the null distribution derived from the
permutation tests (𝑃 < 0.05, corrected).
2.7. Correlation with Clinical Scores. We performed corre-
lation analysis to detect possible links between structural
connectivity and clinical scores. We pooled connectivity
matrices between the groups (i.e., PD and SWEDD) into
one long vector and then computed Spearman correlations
with MDS-UPDRS scores for all identified connections.
The Holm-Bonferroni correction was adopted to compute
corrected 𝑃 values in order to reveal significantly correlated
connections.
2.8. Classification Using Identified Connections. The four sig-
nificant connections were fed into a support vector machine
(SVM) classifier framework with linear kernels to separate
between SWEDD and PD. The technical details of the SVM
are found in a review by Vapnik [24]. We applied the leave-
one-out-cross validation method for discrimination of train-
ing and test data because of the limited number of available
subjects. For example, given 37 SWEDD and 40 PD cases,
we assigned one case as the test case and used the remaining
76 cases as the training data for the SVM classifier. The
process was repeated 77 times, choosing a different test case
each time.The SVM classifier seeks a decision boundary that
can effectively separate samples near the decision boundary.
Classifier accuracy, sensitivity, and specificity were computed
by comparing the classifier outcomes with known ground
truth using MATLAB [25].
3. Results
3.1. Structural Connectivity Differences. The stacked connec-
tivity matrices of SWEDD and PD groups were investi-
gated using nonparametric permutation tests in order to
identify elements (i.e., connections between regions) that
distinguished between PD and SWEDD patients. Twenty-
three connections were significantly different between PD
and SWEDD, as shown in Figure 2 and Table 3. Of these
connections, 11 increased in PD compared to SWEDD and
12 decreased in PD compared to SWEDD. Overall, eight con-
nections were significant, with corrected 𝑃 values less than
0.01. Of these connections, three had 𝑃 values less than 0.001,
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Table 3: Identified connections with significant group-wise differences. Significantly different connections are reported in terms of
connectivity values and corrected 𝑃 values. Connectivity values are reported as mean ± standard deviation (SD). Bold text shows identified
connections with significant differences (corrected 𝑃 < 0.001) between PD and SWEDD.
Group-wise differences
Connection Number of fibers (mean ± SD) Corrected 𝑃 value
PD SWEDD
(a) Cortico-cortical connection
L precentral-L posteriorcingulate 4.6 ± 8.23 1.56 ± 2.89 0.028
L paracentral-L superiorfrontal 1.18 ± 1.67 3.21 ± 6.29 0.039
L paracentral-L posteriorcingulate 8.72 ± 8.32 3.48 ± 4.35 <0.001
L posteriorcingulate-L superiorfrontal 11.7 ± 8.96 6.27 ± 6.23 0.003
L parsorbitalis-R superiorfrontal 0.65 ± 3.33 2.18 ± 4.72 0.046
R paracentral-L paracentral 0.65 ± 2.02 2.59 ± 4.5 0.014
R paracentral-R posteriorcingulate 37.7 ± 23.47 17.8 ± 23.3 <0.001
R precentral-R posteriorcingulate 13.1 ± 16.75 5.54 ± 14.3 0.034
R posteriorcingulate-R superiorfrontal 43.67 ± 27.54 19.94 ± 21.7 <0.001
R posteriorcingulate-R superiorparietal 10.45 ± 17.27 3.00 ±6.78 0.005
R rostralmiddlefrontal-R inferiorparietal 1.42 ± 3.20 0.29 ± 1.17 0.045
(b) Cortico-subcortical connection
L pallidum-L frontalpole 0.77 ± 1.51 2.83 ± 6.40 0.045
L pallidum-L postcentral 5.52 ± 9.17 16.08 ± 26.3 0.012
L putamen-L precentral 14.5 ± 8.95 24.86 ± 24.48 0.013
L putamen-L rostralmiddlefrontal 34.87 ± 30.86 21.83 ± 21.34 0.035
L caudate-L rostralmiddlefrontal 37.5 ± 41.4 15.59 ± 24.66 0.027
L thalamusproper-L rostralmiddlefrontal 7.27 ± 9.75 3.27 ± 5.02 0.007
R pallidum-R superiorfrontal 1.50 ± 2.76 4.57 ± 7.97 0.022
(c) Subcortical connection
L caudate-L putamen 2.28 ± 3.34 5.59 ± 7.58 0.009
R putamen-R pallidum 2.28 ± 2.33 4.51 ± 3.98 0.002
Brainstem-L putamen 3.80 ± 5.71 7.78 ± 10.96 0.046
Brainstem-L caudate 2.00 ± 4.29 4.51 ± 6.46 0.048
Brainstem-R thalamusproper 31.48 ± 18.72 42.08 ± 23.13 0.029
including the connections between the paracentral gyrus and
posterior cingulate gyrus in the left hemisphere, between the
posterior cingulate gyrus and superior frontal lobe in the
right hemisphere, and between the posterior cingulate gyrus
and paracentral gyrus in the right hemisphere. Further details
regarding identified connections are reported in Table 3.
3.2. Correlations between Identified Connections and Clinical
Scores. Correlation analysis was performed to identify possi-
ble links between structural connectivity and MDS-UPDRS-
III score. The approach was similar to that in the previous
section, which sought connections that distinguished two
groups, except that, in this case, we sought connections
that were significantly correlated with MDS-UPDRS score.
Spearman’s correlation was adopted because clinical scores
are categorical measurements. Figure 3 shows significantly
correlated connections with MDS-UPDRS score in the 39
ROIs. Only a few of the identified connections with group-
wise differences were observed to be significantly correlated
(corrected 𝑃 < 0.001) with MDS-UPDRS score, as shown in
bold text in Table 4. Four connections had significant group-
wise differences in structural connectivity and correlation
with clinical scores. Clinical scores were correlated with the
connection between the precentral gyrus and putamen in the
left hemisphere (𝑟 = 0.54, corrected 𝑃 < 0.001), between
the posterior cingulate gyrus and superior frontal lobe in the
right hemisphere (𝑟 = 0.54, corrected 𝑃 < 0.001), between
the posterior cingulate gyrus and paracentral gyrus in the
right hemisphere (𝑟 = 0.56, corrected 𝑃 < 0.001), and
between the paracentral gyrus and superior frontal lobe in
the left hemisphere (𝑟 = −0.32, corrected 𝑃 < 0.001).
3.3. Classifier Performance. The SVM classifier using linear
kernels was applied to separate SWEDD and PD cases.
Accuracy, sensitivity, and specificity of the classifier are
reported in Table 5 for distinguishing between PD and
SWEDD cases. Overall, the classification results were good
(sensitivity, specificity, and accuracy were 78.38%, 77.50%,
and 77.92%, resp.).
4. Discussion
We showed that PD and SWEDD patients might be distin-
guished using connectivity values derived from fiber connec-
tions. The four connections that distinguished between PD
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Figure 3: Connections and correlations with MDS-UPDR-III. The significantly correlated connections were rendered (a). 𝑅-values (b) and
corrected 𝑃 values (c) of significantly correlated connections with MDS-UPDRS-III (corrected 𝑃 < 0.001) are plotted.
and SWEDD also correlated well with clinical scores, indi-
cating their relevance. Furthermore, our study successfully
classified between PD and SWEDD using these identified
connections. This was a proof of concept study, however,
and our findings should be interpreted cautiously in terms
of clinical application. Further research with more samples is
needed to validate our findings.
Among cortico-cortical connections, bilateral paracen-
tral-posterior cingulate, precentral-posterior cingulate, and
posterior cingulate-superior frontal connections showed
decreased connectivity in SWEDD compared to PD patients.
These results are consistent with a recent MRI study [13, 26,
27].The connections and related regions that were previously
reported to have increased functional connectivity for PD
patients are in the sensorimotor cortex, SMA, cingulate
gyrus, primary motor cortex, and parietal cortex [13]. Similar
connections and regions were identified using diffusion-
weightedMRI in PD patients [27]. A previous study reported
reduced fractional anisotropy (FA) values in the frontal lobe,
premotor area, and cingulate in PD patients [26]. Among
subcortical-cortical connections, seven showed significant
group-wise differences. Pallidum-frontal pole, pallidum-
postcentral gyrus, and putamen-precentral gyrus connec-
tions in the left hemisphere decreased in PD compared
to SWEDD. Rostral middle frontal gyrus-putamen, rostral
middle frontal gyrus-caudate, and rostral middle frontal
gyrus-thalamus connections increased in PD compared to
SWEDD. These results corroborate previous studies using
fMRI and diffusion MRI in PD patients [8, 13]. A decrease
in functional connectivity using fMRI was reported in the
left putamen, SMA, and DLPFC in PD patients compared
to NCs [13]. Other studies using diffusion MRI have shown
that FA values in the putamen and caudate are lower in
PD compared to NCs [8]. Within subcortical connections,
five were significantly different between PD and SWEDD,
in agreement with existing studies [8, 28–30]. Structural
connectivity studies of PD patients have shown a reduc-
tion in connectivity in the nigrostriatal tract (connections
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Table 4: Correlation with clinical scores was investigated. Structural connectivity values based on the number of fibers connecting two
regions are reported within the identified connections. Correlations between structural connectivity and MDS-UPDSR score are reported
as Spearman correlation coefficients, with corrected 𝑃 values in the rightmost column. Bold text shows the connections that significantly
correlated with MDS-UPDRS-III (corrected 𝑃 < 0.001).
Correlation with MDS-UPDRS-III score
Connection Number of fibers (mean ± SD) Corr coef. (corrected 𝑃 value)
PD SWEDD Total
(a) Cortico-cortical
connection
L precentral-L posteriorcingulate 4.6 ± 8.23 1.56 ± 2.89 3.14 ± 6.39 0.16 (1)
L paracentral-L superiorfrontal 1.18 ± 1.67 3.21 ± 6.29 2.15 ± 4.61 −0.32 (<0.001)
L paracentral-L posteriorcingulate 8.72 ± 8.32 3.48 ± 4.35 6.21 ± 7.17 0.15 (1)
L posteriorcingulate-L superiorfrontal 11.7 ± 8.96 6.27 ± 6.23 9.09 ± 8.20 0.04 (1)
L parsorbitalis-R superiorfrontal 0.65 ± 3.33 2.18 ± 4.72 1.39 ± 4.10 0.01 (1)
R paracentral-L paracentral 0.65 ± 2.02 2.59 ± 4.5 1.58 ± 5.56 0.03 (1)
R paracentral-R posteriorcingulate 37.7 ± 23.47 17.8 ± 23.3 28.19 ± 25.33 0.56 (<0.001)
R precentral-R posteriorcingulate 13.1 ± 16.75 5.54 ± 14.3 9.47 ± 15.98 0.17 (0.992)
R posteriorcingulate-R superiorfrontal 43.67 ± 27.54 19.94 ± 21.7 32.27 ± 27.48 0.54 (<0.001)
R posteriorcingulate-R superiorparietal 10.45 ± 17.27 3.00 ± 6.78 6.87 ± 13.74 0.27 (0.057)
R rostralmiddlefrontal-R inferiorparietal 1.42 ± 3.20 0.29 ± 1.17 0.88 ± 2.50 0.03 (1)
(b) Cortico-
subcortical
connection
L pallidum-L frontalpole 0.77 ± 1.51 2.83 ± 6.40 1.76 ± 4.65 −0.04 (1)
L pallidum-L postcentral 5.52 ± 9.17 16.08 ± 26.3 10.60 ± 19.98 0.18 (0.85)
L putamen-L precentral 14.5 ± 8.95 24.86 ± 24.48 19.48 ± 18.77 0.54 (<0.001)
L putamen-L rostralmiddlefrontal 34.87 ± 30.86 21.83 ± 21.34 28.61 ± 27.34 0.09 (1)
L caudate-L rostralmiddlefrontal 37.5 ± 41.4 15.59 ± 24.66 26.97 ± 35.90 −0.08 (1)
L thalamusproper-L rostralmiddlefrontal 7.27 ± 9.75 3.27 ± 5.02 5.35 ± 8.05 0.02 (1)
R pallidum-R superiorfrontal 1.50 ± 2.76 4.57 ± 7.97 2.97 ± 6.03 0.01 (1)
(c) Subcortical
connection
L caudate-L putamen 2.28 ± 3.34 5.59 ± 7.58 3.7 ± 5.98 0.06 (1)
R putamen-R pallidum 2.28 ± 2.33 4.51 ± 3.98 3.35 ± 3.40 −0.14 (1)
Brainstem-L putamen 3.80 ± 5.71 7.78 ± 10.96 5.71 ± 8.81 0.15 (1)
Brainstem-L caudate 2.00 ± 4.29 4.51 ± 6.46 3.21 ± 5.55 0.01 (1)
Brainstem-R thalamusproper 31.48 ± 18.72 42.08 ± 23.13 36.57 ± 21.49 0.19 (0.648)
Table 5: Classifier performance to distinguish between PD and
SWEDD.
Group Sensitivity (%) Specificity (%) Accuracy (%)
SWEDD versus PD 78.38 77.50 77.92
among SN, STN, putamen, and pallidum) using DTI [28].
Others report decreased FA values in the substantia nigra,
caudate, and putamen in PD patients [8]. One functional
connectivity study showed a decreased connection in the
pallidum-putamen using resting state functional MRI (rs-
fMRI) [29]. PD patients also showed decreased fiber counts
in SN-putamen and pallidum connections [30].
Existing connectivity studies have mainly explored dif-
ferences between NCs and PD patients [8, 13, 26–31].
There is a lack of comparable studies comparing SWEDD
and PD using structural connectivity. The previous discus-
sion contrasting our findings with existing literature was
largely derived from comparisons of PD patients and NCs,
not necessarily PD and SWEDD. The existing literature
describes various MRI techniques, including resting state
fMRI, structural MRI, and diffusion MRI [8, 13, 26–31].
Comparisons between our findings and existing research
should consider the imagingmodalities used in those studies.
Some researchers have adopted non-MRI and non-SPECT
approaches to studying PD and SWEDD [32, 33]. One study
successfully adopted electrophysiological tremor parameters
to distinguish between tremor-dominant PD and SWEDD
[32]. In addition, a sonography study attained 85% accuracy
in distinguishing PD from SWEDD [33].
Our results showed significant connections between sub-
cortical and cortical structuresmostly in left intrahemisphere
connections, as shown in Table 3. One possible explana-
tion might be related to lateralized dopamine transporter
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Table 6: Correlations between DaT imaging measures and MDS-UPDRS score.
Left caudate SBR Left putamen SBR Right caudate SBR Right putamen SBR
𝑅-value −0.33 −0.33 −0.29 −0.36
𝑃 value 0.003 0.003 0.011 0.001
uptake in PD. Previous studies using I123-IBZM SPECT
revealed lateralized difference in the striatal uptake of I123-
IBZM, which implies lateralized availability of dopamine-
D2 receptors [34]. Another possible explanation might be
the handedness of patients. Our study considered largely
right-handed patients, which could be one factor leading
to the lateralized connectivity patterns shown in this study.
Some studies have found that right-handed PD patients
have significantly lower dopamine transporter uptake in the
left putamen compared to the right putamen [31]. Thus,
lateralized connectivity differences in our study might be
related to right-handed PD patients with reduced dopamine
uptake in the left striatum. Side of disease onset in PDpatients
might differentially affect connectivity patterns [35, 36]. A
previous study reported that an association between right-
sided symptoms in PD and depression was related to the
side of disease onset [37]. Unfortunately, the PPMI database
lacked side of disease onset information; thus, we could not
quantify the difference between sides of disease onset.
DaT imaging by definition can distinguish between PD
and SWEDD [4, 16]. Our study showed that an MRI-
basedmeasure (i.e., DTI tractography) could also distinguish
between PD and SWEDD. MRI has advantages over SPECT,
as it is more readily available at clinical sites and does
not expose patients to radiation. Our results using DTI
showed better correlation with clinical variables such as
MDS-UPDRS III. We reported a correlation value of 0.54
between DTI results and MDS-UPDRS, while correlation
between DaT imaging measures (i.e., striatal binding ratio
(SBR) of the caudate and putamen) and MDS-UPDRS from
the same PPMI data showed correlation values ranging from
−0.36 to −0.29, as shown in Table 6.
SWEDD patients are heterogeneous, with many different
underlying conditions.ModernMRI techniques can quantify
diffusion (as shown in DTI), perfusion, and other tissue
properties [38–40]. Applying various MRI techniques to
SWEDD patients could reveal differences that relate to
various underlying conditions of SWEDD such as essen-
tial tremor and dystonic tremor. Unfortunately, the PPMI
database simply did not have enough samples in the SWEDD
group to subdivide them into different subgroups based on
underlying condition.We leave this important topic for future
research, which might be feasible as the PPMI collects more
cases.
Our study has some limitations. First, DTI itself suf-
fers from limitations including (1) inability to distinguish
between efferent and afferent connections and (2) capacity
to account for only major fiber tracts due to limited voxel
resolution. Adopting an advanced form of DTI known as
high-angular resolution diffusion imaging (HARDI) would
allow for complex modeling within a voxel; however, HARDI
requires longer scan times compared to DTI [41]. Second,
multimodal imaging could be adopted to better explore the
brain network. For example, we could have used additional
fMRI to complement the DTI data [42]. Multimodal analysis
of the brain network would allow incorporation of comple-
mentary information derived from different modalities in
order to better quantify differences between PD and SWEDD.
Third, our study only considered SWEDD and PD, leaving
out normal controls. Future studies need to consider all
three groups (i.e., PD, SWEDD, and NCs groups) so that the
identity of SWEDD can be better established.
5. Conclusion
We identified four structural connections that distinguished
between PD and SWEDD and also correlated well with
MDS-UPDRS score. These findings confirm correlations
between important connections and well-established clinical
scores. Our study successfully distinguished between PD
and SWEDD using these identified connections. Thus, our
findings might serve as a first to step to investigate whether
SWEDD patients have a unique connectivity profile.
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